EPA’s conditional registration of Aminocyclopyrachlor and Clothianidin illustrates the dangers of approving a pesticide before completing a comprehensive appraisal of its risks

The agribusiness conglomerate DuPont has received more than 30,000 damage claims arising from its sale of a pesticide that resulted in death and injury to hundreds of thousands of evergreen trees, particularly Norway spruce and white pine. DuPont marketed the pesticide, sold under the trade name Imprelis, based on a conditional registration that the U.S. Environmental Protection Agency (EPA) granted in 2010. The active ingredient in Imprelis, aminocyclopyrachlor, is biologically active in soil and rapidly absorbed by roots and leaves. Aminocyclopyrachlor is in the chemical class of the pyrimidine carboxylic acids, which is similar to pyridine carboxylic acid herbicides that includes the herbicides aminopyralid, clopyralid and picloram. The two classes of herbicides share characteristics, including high persistence in the environment, systemic incorporation into plants and high toxicity during seedling emergence. Conditional registration is allowed under Section 3(c)(7) of the Federal Insecticide, Fungicide and Rodenticide Act prior to the registrant submitting all statutorily required data. EPA is authorized to grant a conditional registration on the assumption that no unreasonable adverse effects on environmental and human health will result.

As the case of Imprelis confirms, conditional registration actually allows EPA to bypass statutory safeguards and rush pesticides with unknown and unevaluated risks to market. It often takes years before EPA receives the relevant data, and sometimes that data is not submitted before the 15-year reregistration review cycle required for all pesticides.

EPA’s decision to grant conditional registration to the systemic insecticide clothianidin further illustrates the dangers of approving a pesticide before completing a rigorous and comprehensive appraisal of its risks. EPA granted a conditional registration to clothianidin in 2003 despite the absence of a required field study satisfying the statutory requirement that the pesticide not impose “unreasonable adverse risks” to pollinators, including honey bees. Nine years later, EPA still lacks an acceptable study satisfying this legal requirement yet the agency continues to allow the widespread use of clothianidin and similar neonicotinoid insecticides. Substantial new research is emerging that neonicotinoid insecticides have cumulative, sublethal effects on bees including neurobehavioral and immune system disruptions that are contributing to the Colony Collapse Disorder that is decimating bee hives globally.

Source:
EcoWatch, 07-06-2012
http://ecowatch.org/2012/duponts-liability/